News

Public · Published

HCA Healthcare, Inc. Stock 12‑Month Price Target Raised to $466.75

The average 12-month price target for HCA Healthcare stock rose from $464.25 to $466.75, based on estimates from 20 analysts. Forecasts range from $380 to $579 per share, and the consensus rating remains Buy across 29 analysts.

Published:

Updated:

What happened

The average 12-month price target for HCA Healthcare stock rose from $464.25 to $466.75, based on estimates from 20 analysts. Forecasts range from $380 to $579 per share, and the consensus rating remains Buy across 29 analysts.

Confirmed

Global impact / market context

A higher average target means analysts on balance expect more upside in the shares than before. The Buy consensus suggests most covering analysts still see the stock as attractive, which can influence how investors position money in healthcare stocks.

Analyst inference

The spread from $380 to $579 shows analysts disagree widely about HCA's future value. That disagreement means estimates are less uniform, so individual forecasts should be read with caution rather than treated as a single reliable view.

Analyst inference

What to watch

  1. Watch whether the average target keeps rising from $466.75 as the 20 analysts update their estimates, since the range of forecasts still runs from $380 to $579 per share. Confirmed
  2. Track whether the consensus Buy rating, currently 15 Buys, 12 Holds and 2 Sells across 29 analysts, shifts as new recommendations are published. Proposed
  3. Watch whether analyst revisions become more tightly grouped, which would signal growing agreement on HCA's value and could affect investor positioning in the stock. Analyst inference

Evidence

  • Original source link unavailable